foxo4-dri cancer FOXO4-DRI: The Senolytic Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness FOXO4-DRI: A Breakthrough Peptide Targeting

Scientists use it as a model compound to investigate strategies for improving the bioavailability, half-life, and tissue targeting of peptide therapeutics

PlexusDx recommends contacting your provider if temperature exposure exceeds 2 hours to determine whether your vial should be replaced

Ships same day

Retarutide (LY3437943) is a triple agonist peptide of glucagon receptor (GCGR), glucose-dependent insulin-promoting peptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R)

This peptide has shown a lot of promise and is generally well-tolerated when used properly and under the care of a qualified healthcare provider, so its an easy one to put on your short list